Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HLA-G Antigens | 6 | 2022 | 13 | 1.420 |
Why?
|
| Histocompatibility Antigens Class I | 5 | 2019 | 107 | 1.010 |
Why?
|
| 3' Untranslated Regions | 6 | 2022 | 180 | 0.990 |
Why?
|
| Genotype | 12 | 2022 | 2716 | 0.720 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2022 | 3360 | 0.660 |
Why?
|
| Cytomegalovirus Infections | 4 | 2018 | 226 | 0.610 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2022 | 2857 | 0.600 |
Why?
|
| Abortion, Habitual | 2 | 2019 | 18 | 0.560 |
Why?
|
| Graft Rejection | 3 | 2019 | 566 | 0.530 |
Why?
|
| Interleukin-1beta | 2 | 2020 | 166 | 0.440 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 2 | 2018 | 18 | 0.440 |
Why?
|
| Dyspepsia | 2 | 2020 | 108 | 0.440 |
Why?
|
| Genetic Variation | 2 | 2022 | 1593 | 0.420 |
Why?
|
| Kidney Transplantation | 6 | 2019 | 574 | 0.400 |
Why?
|
| Mesocricetus | 1 | 2021 | 74 | 0.370 |
Why?
|
| Polymorphism, Genetic | 3 | 2018 | 810 | 0.350 |
Why?
|
| Receptors, CCR5 | 1 | 2019 | 31 | 0.320 |
Why?
|
| Fas Ligand Protein | 1 | 2019 | 37 | 0.310 |
Why?
|
| fas Receptor | 1 | 2019 | 48 | 0.300 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2019 | 72 | 0.300 |
Why?
|
| Gene Frequency | 5 | 2021 | 750 | 0.300 |
Why?
|
| HIV Infections | 3 | 2019 | 2020 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 180 | 0.290 |
Why?
|
| Brazil | 5 | 2021 | 138 | 0.290 |
Why?
|
| Hepatitis B | 1 | 2019 | 171 | 0.280 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2017 | 14 | 0.270 |
Why?
|
| Benzoxazines | 1 | 2017 | 22 | 0.270 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 412 | 0.260 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2017 | 36 | 0.260 |
Why?
|
| Living Donors | 4 | 2019 | 116 | 0.250 |
Why?
|
| Transplantation Tolerance | 1 | 2016 | 15 | 0.250 |
Why?
|
| Gastritis | 1 | 2020 | 373 | 0.250 |
Why?
|
| Haplotypes | 4 | 2022 | 544 | 0.240 |
Why?
|
| Helicobacter pylori | 2 | 2020 | 1335 | 0.240 |
Why?
|
| Helicobacter Infections | 2 | 2020 | 1277 | 0.240 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1206 | 0.230 |
Why?
|
| Central Nervous System | 1 | 2017 | 285 | 0.230 |
Why?
|
| Hepatitis C, Chronic | 1 | 2019 | 370 | 0.230 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 466 | 0.220 |
Why?
|
| Genetic Association Studies | 4 | 2022 | 858 | 0.210 |
Why?
|
| Alleles | 5 | 2022 | 1693 | 0.200 |
Why?
|
| Adult | 15 | 2022 | 31737 | 0.200 |
Why?
|
| Middle Aged | 14 | 2022 | 29012 | 0.190 |
Why?
|
| Inflammation | 1 | 2020 | 1545 | 0.190 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4725 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 996 | 0.170 |
Why?
|
| Prognosis | 5 | 2022 | 5040 | 0.160 |
Why?
|
| Female | 17 | 2022 | 71446 | 0.160 |
Why?
|
| BK Virus | 1 | 2019 | 61 | 0.150 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 2745 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1402 | 0.150 |
Why?
|
| Polyomavirus Infections | 1 | 2019 | 91 | 0.150 |
Why?
|
| Virus Replication | 2 | 2019 | 637 | 0.140 |
Why?
|
| Kidney Diseases | 2 | 2019 | 493 | 0.140 |
Why?
|
| Viral Load | 2 | 2021 | 407 | 0.140 |
Why?
|
| Viremia | 1 | 2018 | 132 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 268 | 0.130 |
Why?
|
| Male | 13 | 2021 | 65400 | 0.120 |
Why?
|
| Humans | 17 | 2022 | 133185 | 0.110 |
Why?
|
| Transplant Recipients | 3 | 2018 | 226 | 0.090 |
Why?
|
| Coinfection | 2 | 2019 | 184 | 0.090 |
Why?
|
| Alcoholism | 1 | 2014 | 249 | 0.090 |
Why?
|
| Cricetinae | 1 | 2021 | 394 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2022 | 258 | 0.090 |
Why?
|
| Tissue Donors | 2 | 2018 | 507 | 0.080 |
Why?
|
| Young Adult | 3 | 2022 | 9970 | 0.080 |
Why?
|
| Hepatitis C | 1 | 2014 | 388 | 0.080 |
Why?
|
| Aged | 4 | 2022 | 21475 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 492 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 7161 | 0.080 |
Why?
|
| Hepatitis B virus | 1 | 2019 | 142 | 0.070 |
Why?
|
| Pancreas Transplantation | 1 | 2018 | 31 | 0.070 |
Why?
|
| Valine | 1 | 2018 | 113 | 0.070 |
Why?
|
| Sex Factors | 1 | 2021 | 1354 | 0.070 |
Why?
|
| CD4-CD8 Ratio | 1 | 2017 | 13 | 0.070 |
Why?
|
| Alkynes | 1 | 2017 | 26 | 0.070 |
Why?
|
| Cyclopropanes | 1 | 2017 | 69 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2020 | 280 | 0.060 |
Why?
|
| Adolescent | 3 | 2022 | 20592 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2585 | 0.060 |
Why?
|
| HIV-1 | 1 | 2019 | 486 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1134 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3170 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1374 | 0.060 |
Why?
|
| Pregnancy | 2 | 2019 | 7593 | 0.060 |
Why?
|
| Lung | 1 | 2021 | 1565 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 1690 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3433 | 0.050 |
Why?
|
| Omeprazole | 1 | 2018 | 102 | 0.040 |
Why?
|
| Anti-Ulcer Agents | 1 | 2018 | 115 | 0.030 |
Why?
|
| Clarithromycin | 1 | 2018 | 127 | 0.030 |
Why?
|
| Amoxicillin | 1 | 2018 | 125 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 6577 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 6309 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1652 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1833 | 0.030 |
Why?
|
| Educational Status | 1 | 2014 | 295 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 1751 | 0.020 |
Why?
|
| Kidney | 1 | 2018 | 1346 | 0.020 |
Why?
|
| Animals | 1 | 2021 | 35915 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5447 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5173 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2670 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3748 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 13067 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 10933 | 0.010 |
Why?
|
Tomoya Michita's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_